Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
103.50    0.00 (0.00%)
Bid:
102.00
Ask:
105.00
Spread: 3.00 (2.941%)
Market Cap: £61.62m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Shareholder returns update

12 Apr 2023 07:05

RNS Number : 8844V
Crystal Amber Fund Limited
12 April 2023
 

12 April 2023

CRYSTAL AMBER FUND LIMITED

("Crystal Amber Fund" or the "Fund")

 

Shareholder returns update

Within the Fund's interim results for the six months to 31st December 2022 published last month, it was stated that the Board remains optimistic that the Fund will return significant disposal proceeds to shareholders in the second half of 2023, and that this will be principally determined by the outcome of the current recommended acquisition of Hurricane Energy plc ("Hurricane").

 

The Board notes that on 6 April 2023, Hurricane published a circular in relation to the recommended acquisition of the entire issued, and to be issued, share capital of Hurricane by Prax (the "Acquisition") to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme") setting out the full terms and conditions of the Scheme and an expected timetable of events (the "Scheme Document"). In addition to Court and Hurricane shareholder approval, the Scheme is also subject to satisfaction (or, where applicable, waiver) of the other conditions set out in the Scheme Document, including approval from the North Sea Transition Authority ("NSTA") and approval under the United Kingdom National Security and Investment Act 2021 ("NSIA"), and the approval of the Court. The Scheme is expected to become effective in Q2 2023.

 

A meeting of Hurricane shareholders to approve the Scheme has been set for 4 May 2023. Cash consideration due under the Scheme and payment of special dividends due pursuant to the Scheme are scheduled within 14 days of the Scheme becoming effective. The cash consideration due to the Fund upon the Scheme becoming effective is £34.7 million, equivalent to 41.6p per Crystal Amber share ("the Initial Consideration"). In addition, the Fund could receive deferred consideration units with a value up to £37.3 million, equivalent to an additional 44.8p per Crystal Amber share. The total potential consideration due relating to the sale of the Fund's shareholding in Hurricane would be £72 million, equivalent to 86.5p per Crystal Amber share.

 

Upon the Scheme receiving Hurricane shareholder and Court approval on 4 May 2023, the Fund intents to consult with major shareholders regarding the treatment of the disposal proceeds. The Fund intends to announce a substantial return of capital, as soon as practical, with a view to returning capital immediately after the receipt of the Initial Consideration. As previously announced, the Fund intends to retain sufficient liquidity out of the Initial Consideration to continue to fund growth at GI Dynamics and protect the value of its holding in De La Rue.

 

Earlier today Crystal Amber announced that the net asset value per share on 31 March 2023 was 117.4p. This comprises 49.1p per share relating the holding in Hurricane and a net 68.3p for the Fund's other assets and liabilities. On the assumption that the full consideration relating to Hurricane of 86.5p per Crystal Amber share had been received on 31 March 2023, the pro forma net asset value per share on 31 March 2023 would have increased by 37.4p per share to 154.8p per Crystal Amber share.

 

A further announcement will be made in due course.

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com

 

Allenby Capital Limited - Nominated Adviser

David Worlidge/Jeremy Porter/Dan Dearden-Williams

Tel: 020 3328 5656

 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLDSAILLIV
Date   Source Headline
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20255:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20254:15 pmRNSMonthly Net Asset Value
16th Dec 20255:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20256:18 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20255:43 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
9th Dec 20255:42 pmRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20255:36 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20255:41 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Dec 202510:17 amRNSShare Buyback Programme
2nd Dec 20251:08 pmRNSResult of AGM
1st Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Nov 20256:07 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20256:30 pmRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20257:00 amRNSShare Buyback Programme
20th Nov 20257:00 amRNSMonthly Net Asset Value
18th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 20256:05 pmRNSTransaction in Own Shares and Total Voting Rights
17th Nov 20255:59 pmRNSHolding(s) in Company
14th Nov 20256:11 pmRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20257:05 amRNSProposed change of strategy and investment manager
13th Nov 20255:39 pmRNSTransaction in Own Shares and Total Voting Rights
6th Nov 20257:00 amRNSNotice of AGM
31st Oct 20255:30 pmRNSTotal Voting Rights
27th Oct 20256:13 pmRNSTransaction in Own Shares and Total Voting Rights
24th Oct 20259:51 amRNSMonthly Net Asset Value
24th Oct 20259:50 amRNSMonthly Net Asset Value
24th Oct 20259:48 amRNSMonthly Net Asset Value
24th Oct 20259:47 amRNSMonthly Net Asset Value
20th Oct 20256:29 pmRNSTransaction in Own Shares and Total Voting Rights
20th Oct 202511:11 amRNSShare Buyback Programme
17th Oct 20257:00 amRNSFinal Results
16th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
7th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
30th Sep 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20255:26 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Sep 20257:00 amRNS-RMorphic Medical Inc. appoints new CFO
10th Sep 20255:21 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20255:29 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20255:31 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.